Areva Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AREVA PHARMS, and what generic and branded alternatives to AREVA PHARMS drugs are available?
AREVA PHARMS has five approved drugs.
Drugs and US Patents for Areva Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Areva Pharms | TERBUTALINE SULFATE | terbutaline sulfate | INJECTABLE;INJECTION | 200122-001 | Nov 8, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Areva Pharms | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 211263-002 | Oct 1, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Areva Pharms | FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 208435-001 | Dec 18, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.